IHA Logo
IHA News
A A A

IHA News

Prof David Gems on BBC1's 'Bang Goes The Theory' 31/03/2014

The IHA's David Gems will feature in the upcoming episode of  ‘Bang Goes the Theory’ which airs on Monday 31st March at 7.30pm on BBC1 and iPlayer. The episode focuses on ageing. http://www.bbc.co.uk/programmes/b00lwxj1 More...

Published: Mar 27, 2014 4:38:10 PM

4 year PhD studentship in the IHA available

A 4 year PhD studentship to study under the supervision of Dr Nazif Alic is now available. The project will examine how genetically or pharmacologically induced changes to gene expression, at the level of transcriptional regulation, extend healthy lifespan in Drosophila melanogaster. To explore this question the student will use a broad range of techniques, including fly genetics and physiology, molecular biology, microscopy, protein chemistry and genomics. The student will gain a broad training in basic biogerontology that will prove relevant to a career in any of the currently relevant aspects of ageing and ageing related-disease. More...

Published: Mar 25, 2014 10:08:50 AM

Dr Jorge Iván Castillo Quan receives Faculty Prize

Congratulations to the IHA's Dr Jorge Iván Castillo Quan who last week was awarded 1st prize for best poster/presentation at the UCL Faculty of Brain Sciences Symposium. This follows his earlier success at UCL Faculty of Life Sciences Research Day held in September 2013, where he also won 1st prize. Well done Jorge!
More...

Published: Feb 25, 2014 3:24:12 PM

Fiona Kerr - Alzheimer's Association International Conference highlights

23 July 2012

Dr Fiona Kerr (Partridge Lab) attended the AAIC in Vancouver, 14th-19th July 2012 last week.

Fiona writes: Over the last three years Genome Wide Association Studies (GWAS) have led to the discovery of variants in 10 new genes which associate with increased risk of developing late-onset Alzheimer’s disease (LOAD). This has required an unprecedented level of collaboration within the AD field, pulling together clinical cohorts world-wide in order to achieve the large data-sets required to obtain meaningful findings in such studies. At this year’s AAIC the excitement re-instated in Alzheimer’s by this research was evident, with scientists looking toward the post-GWAS era of AD discovery. We need to understand more about the effect of these AD-risk variants on gene expression and function, and their potential role in the development of Alzheimer’s disease pathology. If any of these genes are found to play a causal role in AD pathogenesis, beyond simply associating with increased risk for disease development, this could uncover potential new therapeutic targets for the prevention and treatment of LOAD.

Page last modified on 23 jul 12 13:34